CF and non-CF bronchiectasis

CF and non-CF bronchiectasis

The in vitro effect of nebulised hypertonic saline on human bronchial epithelium
Jennifer L. Goralski, Dan Wu, William R. Thelin, Richard C. Boucher, Brian Button

European Respiratory Journal May 2018, 51 (5) 1702652; DOI: 10.1183/13993003.02652-2017
Cured bronchi! Extending the use of nebulised hypertonic saline outside of cystic fibrosis?
Clémence Martin, Lucile Regard, Pierre-Régis Burgel

European Respiratory Journal May 2018, 51 (5) 1800755; DOI: 10.1183/13993003.00755-2018
The clinical significance of oropharyngeal cultures in young children with cystic fibrosis
Oded Breuer, Daan Caudri, Lauren Akesson, Sarath Ranganathan, Stephen M. Stick, André Schultz

European Respiratory Journal May 2018, 51 (5) 1800238; DOI: 10.1183/13993003.00238-2018
Integration of multi-omics datasets enables molecular classification of COPD
Chuan-Xing Li, Craig E. Wheelock, C. Magnus Sköld, Åsa M. Wheelock

European Respiratory Journal May 2018, 51 (5) 1701930; DOI: 10.1183/13993003.01930-2017
Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis
A. Susanne Dittrich, Iris Kühbandner, Stefanie Gehrig, Verena Rickert-Zacharias, Matthew Twigg, Sabine Wege, Clifford C. Taggart, Felix Herth, Carsten Schultz, Marcus A. Mall

European Respiratory Journal Mar 2018, 51 (3) 1701910; DOI: 10.1183/13993003.01910-2017
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Katherine O'Neill, Judy M. Bradley, Alastair Reid, Damian G. Downey, Jacqueline Rendall, John McCaughan, John E. Moore, Michael M. Tunney, J. Stuart Elborn

European Respiratory Journal Feb 2018, 51 (2) 1701704; DOI: 10.1183/13993003.01704-2017
Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers
Miguel Angel Martinez-García

European Respiratory Journal Feb 2018, 51 (2) 1702497; DOI: 10.1183/13993003.02497-2017
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson

European Respiratory Journal Jan 2018, 51 (1) 1702052; DOI: 10.1183/13993003.02052-2017
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson

European Respiratory Journal Jan 2018, 51 (1) 1702053; DOI: 10.1183/13993003.02053-2017
RESPIRE: breathing new life into bronchiectasis
Sanjay H. Chotirmall, James D. Chalmers

European Respiratory Journal Jan 2018, 51 (1) 1702444; DOI: 10.1183/13993003.02444-2017

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us